Komori
Capita (7462) · InitiativeAdvancedLatest M&A and Subsidiary Changes (2026-08-13): "Restated"

Expansion of real-estate leasing and M&A through the acquisition of BioSite Capital as a subsidiary

First written in FY2026-H1. 7 of 14 entries say "Advanced", first in 2026-03-25. Latest entry: 2026-08-13.

14entries
2years
12from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2026-H1Advanced2026-03-25 – 2026-05-14Advanced2026-05-29 – FY20262025: 120252026: 132026
Same theme, other companies
Expansion of Laboratory and Real Estate Leasing Businesses Through the Acquisition of バイオ・サイト・キャピタル as a SubsidiaryA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  2. FY2026AdvancedAnnual report

    「At a meeting of its Board of Directors held on 30 September 2025, the Company resolved to conduct a simplified share delivery, with the Company as the parent company receiving shares and Bio Site Capital Co., Ltd. as the subsidiary company delivering shares. The share delivery was completed on 7 November 2025, making Bio Site Capital Co., Ltd. a subsidiary.」

    The policy of making Bio Site Capital a subsidiary announced in the previous fiscal year was implemented on 7 November 2025, with the Company acquiring 63.76% of the voting rights. Laboratory, real estate leasing, and fund businesses were added as consolidated subsidiaries.
  4. FY2026-H1First statedAnnual report

    「At a meeting of its Board of Directors held on 30 September 2025, the Company resolved to conduct a simplified share delivery, with the Company as the parent company receiving shares and Bio Site Capital Co., Ltd. as the subsidiary company delivering shares. The share delivery was completed on 7 November 2025, making Bio Site Capital Co., Ltd. a subsidiary.」

    The Company acquired 63.76% of the voting rights in Bio Site Capital and made it a subsidiary. The objectives are to expand its market through research facility and office leasing, convert real estate into laboratory facilities, and focus on M&A by leveraging investment personnel and expertise.
Moved together

"Asset replacement through the sale of low-profitability assets and acquisition of higher-profitability properties" moved the same way as this thread, in the same document, in 3 of its 12 moves.

322222★123456
  1. ★This thread
  2. 1Asset replacement through the sale of low-profitability assets and acquisition of higher-profitability properties3×
  3. 2Securing appropriate margins and strengthening non-fuel products2×
  4. 3Stable and consistent dividends2×
  5. 4Expansion of the property-for-sale business2×
  6. 5Business expansion into the Kansai region2×
  7. 6Recognition of impairment losses on fixed assets2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Capita yet. It last moved in the M&A and Subsidiary Changes of 2026-08-13: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion of real-estate leasing and M&A through the acquisition of BioSite Capital as a subsidiary | CAPITA Inc. (7462) | Komori